Host and Microbial Metabolism as Determinants of Antibiotic-induced Disruption in the Microbiome – Brown University’s Peter A. Belenky, PhD
Please join us for this month's Levy CIMAR Science Lunch, presented by Brown University's Peter Belenky, PhD, an Assistant Professor of Molecular Microbiology and Immunology whose work focuses on the responses of microbial communities and isolated microbes to external stress such
How HAMLET, a Human Milk Protein, Kills Bacteria and Reverses Antibiotic Resistance – Lund University’s Anders P. Håkansson, PhD
We are excited to introduce our newest affiliate member, Lund University's Anders P. Håkansson, PhD, who will present on January 27th for our first Levy CIMAR Science Lunch of 2022! His talk is titled, "How HAMLET, a Human Milk Protein,
Microbial Theranostics: A Resistance Combating Strategy – Mayo Clinic’s Robin Patel, MD
The Levy CIMAR proudly welcomes the Mayo Clinic's Robin Patel, MD, to present for our March '22 monthly Science Lunch. Among her many titles at Mayo, Dr. Patel is an Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, a Professor of
Trials and Tribulations of Antimicrobial Drug Development: Assessing the Economic and Political Landscape
We were privileged yesterday to have the Levy CIMAR’s own Kenneth I. Kaitin, PhD, present at our December 2020 Monthly Science Lunch, a seminar series devoted to engaging with and informing our community about the latest news in antimicrobial research,
Monoclonal Ab treatment for SARS CoV2 infection
Veterinary pathologist Amanda J. Martinot (DVM, MPH, PhD) of the Tufts University Cummings School of Veterinary Medicine presented for our Monthly Science Meeting on Thursday, January 28, on two articles of interest in the COVID-19 pandemic: The first on the
Using Metabolomics to Investigate Gut Bacterial Microbiota Dependent Factors of C. difficile Infection
For this month's Levy CIMAR Science Meeting, we are excited to hear from Kyongbum Lee, PhD, (Professor & Chair of Chemical & Biological Engineering at the Tufts School of Engineering) on “Using Metabolomics to Investigate Gut Bacterial Microbiota Dependent Factors
Innovation Solutions to AMR
Kevin Outterson, Esq., Professor of Law at Boston University and Executive Director of the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, will present for this month’s Levy CIMAR Science Meeting on “Innovation Solutions to AMR.” CARB-X is a global partnership hosted at BU Law
Building a Pipeline of AMR Solutions – CARB-X’s Erin Duffy, PhD
Erin Duffy, PhD, is Chief of Research and Development at the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X—a global partnership hosted at Boston University that is focused on supporting developers of promising new antibiotics, diagnostics, and vaccines that tackle the
Achilles’ Heel Proteins Controlling the Acinetobacter Cell Envelope – Northeastern University’s Edward Geisinger, MD, PhD
Please join us for this month’s Levy CIMAR Science lunch on a special date, Thursday, November 18th, at noon. We are excited to welcome Edward Geisinger, MD, PhD, an Assistant Professor of Biology at Northeastern University in Boston and an
From Detection to Predicting Infectious Disease and Antibiotic Resistance Outcomes – BC’s Tim van Opijnen, PhD
We are excited to welcome Tim van Opijnen, PhD, an Associate Professor of Biology at Boston College and an Affiliate member of the Levy CIMAR, to present for our May 2021 Science Lunch. His talk is titled, "From Detection to